-
2024-518835-13-00
5
Suspected Vascular Disease of supra-aortic (carotid/vertebrobasilar),
-
2024-519246-75-01
4
Patients With Muscle-Invasive Bladder Cancer
-
2024-519298-21-00
5
Cancer-Associated Thrombosis (CAT).
-
2024-519573-19-00
4
melanoma
-
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
-
2024-519753-11-00
4
Resectable borderline pancreatic adenocarcinoma
-
2024-519786-22-01
9
metastatic non-small cell lung cancer (NSCLC)
-
2024-519818-31-01
5
Endometrial Cancer
Advanced, Recurrent, Metastatic, or Primary Unresec
-
2024-519894-20-01
5
Adult with an staphylococcal prosthetic joint infection treated with d
-
2024-520140-42-00
5
Patients with primary HPV high-grade squamous intra-epithelial lesions
-
2024-520414-21-00
5
Adult patients with a LVOS with large core within 9 hours of symptoms
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-520565-51-00
5
small cell lung cancer
-
2025-520573-39-00
6
Ultra High Risk of psychosis and first episode psychosis
-
2025-520940-14-00
6
Pyogenic liver abscess
-
2025-520976-25-00
4
Relapsed/refractory multiple myeloma
-
2025-521101-40-00
6
CHRONIC DECOMPENSATED HEART FAILURE
-
2025-521113-13-00
10
Early Parkinson’s Disease
-
2025-521331-36-00
10
Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%)
-
2025-521371-31-00
4
Sepsis
-
2025-521632-12-00
5
Patients on Factor Xa inhibitor treatment needing an urgent interventi
-
2025-521909-40-00
4
Patients with metastatic or locally advanced HER2-low triple-negative
-
2025-522546-52-00
5
patients with chronic respiratory insufficiency due to amyotrophic lat
-
2025-522790-10-00
4
Non Small Cell Lung Cancer